Dr. Vaughn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
181 Taylor Ave
Columbus, OH 43203Phone+1 614-293-9441Fax+1 614-293-6420
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of WashingtonResidency, Internal Medicine, 2008 - 2011
- Emory University School of MedicineClass of 2008
Certifications & Licensure
- OH State Medical License 2019 - 2025
- VA State Medical License 2014 - 2020
- WA State Medical License 2008 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma Start of enrollment: 2015 Oct 01
Publications & Presentations
PubMed
- OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility.Hanieh Taheri, Yang Li, Kevin M Huang, Eman Ahmed, Yan Jin
Cancer Research Communications. 2025-03-01 - What is the optimal strategy for secondary prevention after venous thromboembolism in polycythemia vera?Helen Ajufo, Jennifer Vaughn
Hematology. American Society of Hematology. Education Program. 2024-12-06 - 3 citationsCML and the WHO: Why?Ellin Berman, Neil P Shah, Michael Deninger, Jessica K Altman, Maria Amaya
Journal of Clinical Oncology. 2024-03-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: